SCHEMBL3971304

SCHEMBL3971304

O=C1OC2(CCNC2)c2ccnc(C(=O)C3(c4ccc(OCc5ccc6ccccc6n5)cc4)CC3)c21

nearest known ligand 0.42

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 10/20 0.42
CYSLTR1 Q9Y271 7/20 0.41
CYSLTR2 Q9NS75 6/20 0.41
GPBAR1 Q8TDU6 1/20 0.41
FFAR1 O14842 1/20 0.41
AKR1B1 P15121 1/20 0.41
ALOX5 P09917 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL350865 0.84 ADAM17 (0.36)
SCHEMBL3969701 0.83 RORC (0.36) FFAR1
SCHEMBL3975332 0.82 MAOB (0.36)
SCHEMBL3972419 0.81 NR4A2 (0.39) ALOX5APALOX5
SCHEMBL3907137 0.80 PDE2A (0.32)
SCHEMBL3970810 0.79 AKT1 (0.32)
SCHEMBL3968068 0.78 CTSC (0.35)
SCHEMBL2973860 0.77 HSD11B1 (0.31)
SCHEMBL3977568 0.76 HSD11B1 (0.33)
SCHEMBL3974626 0.75 HSD11B1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756063-A4 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2009-03-25 EP claimed
EP-1756063-A1 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-02-28 EP claimed
WO-2005110992-A1 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2005-11-24 WO claimed